Abstract:Purpose: Alopecia has been reported a distressing side-effect of chemotherapy for breast cancer patients (BCP) that is highly relevant for quality of life during treatment. For the prevention of chemotherapy-induced alopecia, scalp cooling (SC) has been reported to be an effective and safe intervention. However, data on the patient's perspective on effectiveness and applicability of SC in a clinical routine setting are scarce. In this comparative study, we aimed at a longitudinal assessment of patient-reported outcome (PRO) data on the effect of SC on alopecia and its effect on symptoms and functional health when applied in clinical routine in BCP receiving taxane or anthracycline-based chemotherapy. Patients and methods: Study participants were allocated either to the intervention group receiving SC or to the control group based on patient preference (non-randomized study). All patients completed PRO-measures on hair preservation (EORTC Item Library items on hair loss), symptom and functional health measures (EORTC QLQ-C30 and -BR23) and the Body Image Scale (BIS). Outcomes were assessed at chemotherapy start (baseline), mid-chemotherapy, last chemotherapy cycle, 3 months follow-up and 6-9 months follow-up. Results: Overall, we included 113 patients: 75 patients underwent SC (mean age = 51.3 years, 52.7% premenopausal); 38 patients standard care (mean age = 55.6 years, 39.5% premenopausal). A total of 53 patients (70.7%) discontinued SC, with 39 patients (73.5%) stating alopecia as the primary reason. On average, BCP stayed on treatment with the cooling cap for 40.2% of the duration of their chemotherapy (SD 25.3%). In an intention-to-treat analysis, we found no difference between the SC group and the control group with regard to their patient-reported hair loss (p=0.831) across the observation period, overall QOL (p=0.627), emotional functioning (p=0.737), social functioning (p=0.635) and body image (p=0.463) did not differ between groups. Conclusion: We found a high rate of SC-decliners and no beneficial effects of SC for patient-reported hair loss, symptoms and functional health. The efficacy and tolerability of SC applied in a clinical routine setting hence appeared to be limited. The further determination and up-front definition of criteria prognostic for effectiveness of SC may be helpful to identify patient subgroups that may experience a treatment benefit.

Validation and responsiveness of the English version of the Chemotherapy-Induced Alopecia Distress Scale (CADS) in breast cancer patients

Development and validation of the chemotherapy adherence assessment scale (CAAS)

Validation of the Thai Version of the Memorial Symptom Assessment Scaled - Short Form Among Cholangiocarcinoma Patients

CancerSupportSource®-15+: development and evaluation of a short form of a distress screening program for cancer patients and survivors

Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients

Development and validation of the NCC-BC-A scale to assess patient-reported outcomes for breast cancer patients in China

Validation of Mini-Mental Adjustment to Cancer scale in a Moroccan sample of breast cancer women

Designing and Validating a Comprehensive Patient-Reported Outcomes Measure for Ambulatory Cancer Settings: The Revised Edmonton Symptom Assessment System for Cancer

PRO Hair Safe Study: The Patient's Perspective on the Effects of Scalp Cooling on Hair Preservation

Validation of a tagalog version of the EORTC PATSAT-C33 and EORTC OUT-PATSAT7 patient satisfaction questionnaires for patients with cancer undergoing outpatient radiotherapy.

Development and psychometric testing of the symptoms assessment inventory for breast cancer patients receiving chemotherapy

Validation of the state version questionnaire on autonomic regulation (state-aR) for cancer patients

Scalp Cooling in Preventing Persistent Chemotherapy-Induced Alopecia: A Randomized Controlled Trial

Development and Evaluation of a Psychosocial Adaptation Questionnaire for Women with Breast Cancer Treated with Adjuvant Endocrine Therapy: a Single-Centre, Cross-Sectional Study in China

Validación del cuestionario básico de síntomas M. D. Anderson (MDASI) para pacientes con cáncer en población mexicana

Reliability and validity of the Chinese version of the coronary artery disease empowerment scale (CADES) in patients with coronary artery disease after percutaneous coronary intervention

Reliability and Validity of the Arabic Version of the Short Form Supportive Care Needs Survey Questionnaire (SCNS-SF34-A)

Validation of the Simplified Chinese Version of the Memorial Symptom Assessment Scale-Short Form among Cancer Patients.

The reliability and validity of the Chinese version of the Appraisal of Diabetes Scale

Validation of a Chinese version of the short-form Cataldo lung cancer stigma scale

Effect of chemotherapy induced hair-loss on distress levels among cancer patients visiting public and private hospitals of Punjab